UY32429A - Derivados de n-[(6-aza-biciclo[3.2.1]oct-1-il)-aril-metil]-benzamida, su preparacion y su aplicacion en terapeutica - Google Patents
Derivados de n-[(6-aza-biciclo[3.2.1]oct-1-il)-aril-metil]-benzamida, su preparacion y su aplicacion en terapeuticaInfo
- Publication number
- UY32429A UY32429A UY0001032429A UY32429A UY32429A UY 32429 A UY32429 A UY 32429A UY 0001032429 A UY0001032429 A UY 0001032429A UY 32429 A UY32429 A UY 32429A UY 32429 A UY32429 A UY 32429A
- Authority
- UY
- Uruguay
- Prior art keywords
- aza
- oct
- preparation
- application
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0900579A FR2941954B1 (fr) | 2009-02-10 | 2009-02-10 | Derives de n-°(6-aza-bicyclo°3.2.1!oct-1-yl)-aryl-methyl! benzamide, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY32429A true UY32429A (es) | 2010-09-30 |
Family
ID=40935769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001032429A UY32429A (es) | 2009-02-10 | 2010-02-10 | Derivados de n-[(6-aza-biciclo[3.2.1]oct-1-il)-aril-metil]-benzamida, su preparacion y su aplicacion en terapeutica |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2396335A1 (fr) |
| JP (1) | JP2012517412A (fr) |
| KR (1) | KR20110118813A (fr) |
| CN (1) | CN102388050A (fr) |
| AR (1) | AR075380A1 (fr) |
| AU (1) | AU2010212703A1 (fr) |
| BR (1) | BRPI1008544A2 (fr) |
| CA (1) | CA2751866A1 (fr) |
| FR (1) | FR2941954B1 (fr) |
| IL (1) | IL214487A0 (fr) |
| MX (1) | MX2011008459A (fr) |
| SG (1) | SG173607A1 (fr) |
| TW (1) | TW201034667A (fr) |
| UY (1) | UY32429A (fr) |
| WO (1) | WO2010092287A1 (fr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
| FR2861070B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-[phenyl(pyrrolidin-2-yl)methyl]benzamide et n-[(azepan-2-yl)phenylmethyl]benzamide, leur preparation et leur application en therapeutique |
| WO2005058317A1 (fr) * | 2003-12-18 | 2005-06-30 | Glaxo Group Limited | Inhibiteurs du transporteur-1 de la glycine |
| CA2627177A1 (fr) * | 2005-10-28 | 2007-05-10 | Merck & Co., Inc. | Inhibiteurs de transporteurs de glycine de type piperidine |
| CL2007003426A1 (es) * | 2006-11-30 | 2008-04-25 | Cenerx Biopharma Inc | Compuestos derivados de dialquilaminoalquilo de pigavabina; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar trastornos afectivos, depresivos, de ansiedad. |
| WO2009013535A1 (fr) * | 2007-07-23 | 2009-01-29 | Astrazeneca Ab | Dérivés de 2-azabicyclo(2,2,2)octane en tant que modulateurs du récepteur transporteur de type i de la glycine |
-
2009
- 2009-02-10 FR FR0900579A patent/FR2941954B1/fr not_active Expired - Fee Related
-
2010
- 2010-02-09 MX MX2011008459A patent/MX2011008459A/es not_active Application Discontinuation
- 2010-02-09 SG SG2011057213A patent/SG173607A1/en unknown
- 2010-02-09 BR BRPI1008544A patent/BRPI1008544A2/pt not_active Application Discontinuation
- 2010-02-09 KR KR1020117021204A patent/KR20110118813A/ko not_active Application Discontinuation
- 2010-02-09 JP JP2011548759A patent/JP2012517412A/ja not_active Withdrawn
- 2010-02-09 TW TW099104006A patent/TW201034667A/zh unknown
- 2010-02-09 AR ARP100100345A patent/AR075380A1/es unknown
- 2010-02-09 WO PCT/FR2010/050204 patent/WO2010092287A1/fr active Application Filing
- 2010-02-09 AU AU2010212703A patent/AU2010212703A1/en not_active Abandoned
- 2010-02-09 EP EP10708304A patent/EP2396335A1/fr not_active Withdrawn
- 2010-02-09 CA CA2751866A patent/CA2751866A1/fr not_active Abandoned
- 2010-02-09 CN CN2010800156289A patent/CN102388050A/zh active Pending
- 2010-02-10 UY UY0001032429A patent/UY32429A/es not_active Application Discontinuation
-
2011
- 2011-08-07 IL IL214487A patent/IL214487A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2941954A1 (fr) | 2010-08-13 |
| WO2010092287A1 (fr) | 2010-08-19 |
| FR2941954B1 (fr) | 2011-04-08 |
| EP2396335A1 (fr) | 2011-12-21 |
| AR075380A1 (es) | 2011-03-30 |
| SG173607A1 (en) | 2011-09-29 |
| CA2751866A1 (fr) | 2010-08-19 |
| IL214487A0 (en) | 2011-09-27 |
| TW201034667A (en) | 2010-10-01 |
| MX2011008459A (es) | 2011-12-16 |
| KR20110118813A (ko) | 2011-11-01 |
| CN102388050A (zh) | 2012-03-21 |
| AU2010212703A1 (en) | 2011-09-01 |
| BRPI1008544A2 (pt) | 2016-03-15 |
| JP2012517412A (ja) | 2012-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124000T1 (el) | Υποκατεστημενες 5-φθορο-1η-πυραζολοπυριδινες σε κρυσταλλικη μορφη | |
| EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
| CR20140392A (es) | Dihidropirazolonas sustituidas | |
| MX2011008634A (es) | Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia. | |
| BR112013000920A2 (pt) | compostos para a redução de produção de beta-amiloide | |
| EA201290183A1 (ru) | Бензодиазепиновый ингибитор бромодомена | |
| ECSP109903A (es) | Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares | |
| UA96785C2 (uk) | Заміщені похідні оксиндолу та їх застосування як лігандів рецептора вазопресину | |
| CY1117326T1 (el) | Παραγωγο κατεχολαμινης χρησιμο για τη θεραπεια ασθενειας parkinson | |
| EA201270225A1 (ru) | СОЕДИНЕНИЯ ДЛЯ УМЕНЬШЕНИЯ ПРОДУКЦИИ β-АМИЛОИДА | |
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
| MA32784B1 (fr) | Composes aryles substitues par heterocycle comme inhibiteurs de hif | |
| SV2011003802A (es) | Derivados de triazol utiles para el tratamiento de enfermedades | |
| EA201000098A1 (ru) | Производные хиназолинамида | |
| BRPI0923300A2 (pt) | "derivados de nitrato de cilostazol para o tratamento de doenças vasculares e metabólicas" | |
| UY31765A (es) | Dihidropirazolonas sustituidas y su uso | |
| CR20110318A (es) | Compuestos, composición farmacéutica y métodos para utilizarse en el tratamiento de trastornos metabólicos | |
| EA200802223A1 (ru) | 1,5-дифенилпиразолы ii в качестве ингибиторов hsp90 | |
| IN2012DN02502A (fr) | ||
| TR201902057T4 (tr) | Tetrasiklin bileşikleri. | |
| BR112013018298A2 (pt) | compostos para a redução da produção de beta-amiloides | |
| ECSP109961A (es) | Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica | |
| UY33568A (es) | Compuestos que interactuan con proteina reguladora de glucocinasa para el tratamiento de diabetes. | |
| TR201004464A2 (tr) | Kemik erimesi için formülasyon. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20130313 |